Diakonie-Klinikum Stuttgart
Stuttgart, Germany
General hospital in Stuttgart, Baden-Württemberg
Rosenbergstraße 38, 70176 Stuttgart
About Diakonie-Klinikum Stuttgart
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
10
German High-Grade Non-Hodgkin's Lymphoma Study Group
5
German CLL Study Group
4
Aesculap AG
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen
1
German Hodgkin's Lymphoma Study Group
1
Goethe University
1
Gruppo Italiano Malattie EMatologiche dell'Adulto
1
Heidelberg University
1
Hoffmann-La Roche
1
Clinical Trials at Diakonie-Klinikum Stuttgart
During the past decade, Diakonie-Klinikum Stuttgart conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
2001-07-01
Unknown status
220
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
2004-07-01
2013-08-01
Completed
920
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
2004-06-01
2011-01-01
Completed
500
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Diakonie-Klinikum Stuttgart" #1 sponsor was "University of Ulm" with 10 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials
sponsored, "German CLL Study Group" with 4 trials sponsored, "Aesculap AG" with 2 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonie-Klinikum Stuttgart"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "EBMT Solid Tumors Working Party" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Diakonie-Klinikum Stuttgart
According to Clinical.Site data, the most researched conditions in "Diakonie-Klinikum Stuttgart" are
"Acute Myeloid Leukemia" (7 trials), "Lymphoma" (6 trials), "Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Diakonie-Klinikum Stuttgart" in a lesser frequency.
Clinical Trials Intervention Types at Diakonie-Klinikum Stuttgart
Most popular intervention types in "Diakonie-Klinikum Stuttgart" are "Drug" (28 trials), "Biological" (11 trials), "Other" (6 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (8 trials), "Cytarabine" (6 trials), "filgrastim" (6 trials), "radiation therapy" (6 trials) and "vincristine sulfate" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Diakonie-Klinikum Stuttgart
The vast majority of trials in "Diakonie-Klinikum Stuttgart" are
34 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Diakonie-Klinikum Stuttgart
Currently, there are NaN active trials in "Diakonie-Klinikum Stuttgart".
undefined are not yet recruiting,
9 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Diakonie-Klinikum Stuttgart,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Diakonie-Klinikum Stuttgart, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".